A crucial diagnostic tool for assessing prostate health, the PSA-Total (Prostate Specific Antigen Total) test is very useful for identifying and tracking prostate cancer. The PSA-Total test has significance for health heart diagnostics (HHD) even though it is primarily linked to urological assessments. This is especially true considering the wider influence of systemic health disorders like cancer on cardiovascular wellbeing.
Proteins known as prostate specific antigen are produced by the prostate gland’s normal and cancerous cells. Increased total PSA levels can be a sign of benign prostatic hyperplasia, prostate inflammation, or prostate cancer, all of which need different approaches to treatment. The PSA-Total test combines both free PSA and total PSA to determine the total amount of PSA in the blood.